Clinical Trials List
2023-07-01 - 2030-02-28
Phase III
Not yet recruiting1
Recruiting10
ICD-10C53.9
Malignant neoplasm of cervix uteri, unspecified
ICD-10Z51.12
Encounter for antineoplastic immunotherapy
ICD-9180.9
Malignant neoplasm of cervix uteri, unspecified
-
Trial Applicant
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/07/01
Investigators and Locations
Co-Principal Investigator
- 周振揚 無
- 林語涵 無
- 周振揚
- 吳佩瑩 無
- 鄭雅敏 無
- 江佳蓉 無
- Keng-Fu Hsu 無
- Meng-Ru Shen 無
- 黃蘭茵 無
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Ting-Chang Chang 無
- Huei-Jean Huang 無
- HSIU-JUNG TUNG 無
- 周宏學 無
- Angel Chao 無
- 張淑涵 無
- 黃寬仁 無
- Min-Yu Chen 無
- 張宸邠 無
- Chyong-Huey Lai 無
- Cheng-Tao Lin 無
- 陳威君 無
- 黃彥綾 無
- 林士敏 無
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 沈書慧 無
- Yi-Jen Chen 無
- 胡育文 無
- Huann-Cheng Horng 無
- 楊思婷 無
- Yen-Hou Chang 無
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 宋鈺雯 Division of Obstetrics & Gynecology
- Yin-Yi Chang Division of Obstetrics & Gynecology
- Wu-Chou Lin Division of Obstetrics & Gynecology
- 張正昌 Division of Obstetrics & Gynecology
- Wei-Chun Chang Division of Obstetrics & Gynecology
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
36 participants
-
Global
800 participants
